1,700 GP practices contribute patient data for Oxford COVID-19 research

09 Sep 2020

Researchers have hailed a ‘fantastic’ response from more than 1,700 GP practices who have stepped forward to contribute patient data for vital COVID-19 research at the University of Oxford – tripling the amount of data available.

The data, which has already led to important published research on COVID-19 risk factors, has come from a daily pseudonymised feed from participating practices provided by EMIS since July.

EMIS has also given researchers at the University first access to its new powerful clinical data and analytics product. Built on the cloud-based EMIS-X platform, the new EMIS-X Analytics technology is now being piloted in a number of academic studies relating to COVID-19, ahead of its launch to NHS customers.

The response from GPs follows a joint appeal in March by the Oxford Royal College of General Practitioners Research and Surveillance Centre (Oxford RCGP RSC) at Oxford University, and clinical systems supplier EMIS, for practices to share their data under strict governance guidelines.

To date, 1,774 practices covering nearly 10 million patients have volunteered to take part in the COVID-19 research, significantly boosting the Oxford RCGP RSC’s network of practices from last year’s 500 practices.

Professor Simon de Lusignan, Director of the RSC, said he was ‘delighted’ by the response from GPs. “We had a resource before, but it is on a fantastic scale now, and is already helping us to answer important questions about COVID-19.

“The sheer numbers coming forward have surprised and delighted me, but primary care has really stepped up to the plate on all fronts in this crisis. It would be difficult to do this research without carefully coded primary care data. For example, ethnicity is well recorded by many GP practices, and this was vital to help us understand the impact of COVID-19 on BAME communities.”

The data is enabling the researchers to understand the spread of COVID-19, including tracking when it peaks and helping to inform strategy on local social distancing and lockdown. It is also being used to evaluate rapid COVID-19 finger prick tests against swab tests. Some practices are taking part in rapid clinical trials of antibiotics to reduce the duration and severity of the virus.

Dr Shaun O’Hanlon, Chief Medical Officer at EMIS, said: “We are proud that our advanced analytics technology is being deployed to support vital research at The University of Oxford. I’m very grateful to all the GPs who have come forward to share data and take part in the research, along with thousands of patients.

“The COVID-19 outbreak has highlighted the need to obtain good quality data quickly, and the power of data to make a difference. Our technology provides the secure, powerful processing tools needed by researchers, healthcare providers and government to answer important questions quickly by running complex queries over aggregated datasets at speed.”

With the launch of the new EMIS-X Analytics product suite, healthcare organisations and researchers will benefit from:

  • cloud analytics tools designed to deliver scalable insights from large healthcare datasets
  • secure authorised access to data from up to 40 million patient records held by more than 4,000 healthcare organisations, enabling intelligence-driven health transformation
  • ability for analytics partners to deploy their own assured algorithms and applications on the EMIS-X platform and share results with clinicians via EMIS Web
  • ability to integrate artificial intelligence tools to allow users to research, build and deploy state of the art machine learning applications
  • combining datasets from multiple sources to build rich and tailored data resources.

EMIS-X will enable an integrated healthcare ecosystem and revolutionise the UK’s health and care landscape.

Find out more about the EMIS-X vision

Get in touch today

Simpy fill out the details below and we will be in contact with you as soon as we can.

Need help? See our support options here